In the literature review, no analyses were found regarding the relationship between the polymorphisms GPX1 (rs1050450), DIO2 (rs225014) and SEPP1 (rs7579) and the possibility of developing endometrial cancer. This evidence concerns the gene GPX1 and endometrial cancer.